We are live on
!
Find out more
RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.8B
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
-0.31%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.71B
AUM Growth
-$105M
(-3.7%)
Cap. Flow
-$29.7M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
23.72%
Holding
332
New
19
Increased
70
Reduced
176
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$23.9M |
| 2 |
SNBR
Sleep Number
SNBR
|
+$17.4M |
| 3 |
BBBY
Bed Bath & Beyond
BBBY
|
+$7.08M |
| 4 |
IAA
IAA, Inc. Common Stock
IAA
|
+$5.96M |
| 5 |
Bioventus
BVS
|
+$5.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XPO
XPO
|
+$20.8M |
| 2 |
Ziff Davis
ZD
|
+$9.39M |
| 3 |
Nektar Therapeutics
NKTR
|
+$8.49M |
| 4 |
Pool Corp
POOL
|
+$7.21M |
| 5 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
+$7.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.75% |
| 2 | Healthcare | 24.54% |
| 3 | Industrials | 15.71% |
| 4 | Consumer Discretionary | 13.79% |
| 5 | Communication Services | 6.82% |
Similar funds
GC
BP
CIM
JCM
KPM
BFG
ST
MCC
Rice Hall James & Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Rice Hall James & Associates held 332 positions worth $2.71B, down 3.7% from $2.81B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rice Hall James & Associates's Q3 2021 filing shows 19 new, 70 increased, 176 reduced and 23 closed positions. Its largest new stake was GXO Logistics: 305,297 shares worth $23.9M. The largest sale was XPO, an estimated $20.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.
- Rice Hall James & Associates's largest Q3 2021 buy was GXO Logistics: 305,297 shares worth $23.9M.
- Rice Hall James & Associates added most to Bed Bath & Beyond in Q3 2021, an estimated $7.08M increase.
- Rice Hall James & Associates's biggest Q3 2021 reduction was XPO, cutting an estimated $20.8M.
- Rice Hall James & Associates fully exited Nektar Therapeutics in Q3 2021, selling an estimated $8.49M.
- Rice Hall James & Associates's ten largest holdings make up 24% of its $2.71B portfolio in Q3 2021.
- Rice Hall James & Associates opened 19 new positions and closed 23 in Q3 2021.
- Rice Hall James & Associates's portfolio value fell 3.7% quarter-over-quarter to $2.71B.
Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.